Patents Assigned to Collagenesis, Inc.
  • Patent number: 6299856
    Abstract: Disclosed herein is a method for treating a malignancy in an animal by introducing into the animal a radioactive isotope, or stable element subsequently made radioactive, covalently linked to a collagen. Also disclosed herein are such radiolabeled collagen compositions.
    Type: Grant
    Filed: February 3, 2000
    Date of Patent: October 9, 2001
    Assignee: Collagenesis, Inc.
    Inventors: Dale P. DeVore, Joel D. Magerman
  • Patent number: 6204365
    Abstract: A method of smoothing irregular corneal surfaces and removing protuberances from corneal surfaces by photoablative eximer laser keratectomy is provided. Collagen compositions for use in making collagen modulators useful in photoablative procedures are described. These compositions are applied to irregular corneal surfaces in sufficient amounts to at least fill in depressions or other irregularities on a corneal surface and are converted into a modulator, as a gel or polymerized film, prior to photoablation. The collagen modulators facilitate the photoablative smoothing of irregular corneal surfaces and protect adjacent corneal tissue from undesired photoablation.
    Type: Grant
    Filed: January 18, 1999
    Date of Patent: March 20, 2001
    Assignee: Collagenesis, Inc.
    Inventors: Dale P. Devore, Richard A. Eiferman
  • Patent number: 6197934
    Abstract: Disclosed herein are collagen films which rapidly dissolve at 35° C. Also disclosed are methods for the preparation of the collagen films and their use as a vehicle for delivering a dose of therapeutic compound to a specific tissue site.
    Type: Grant
    Filed: May 22, 1998
    Date of Patent: March 6, 2001
    Assignee: Collagenesis, Inc.
    Inventors: Dale P. DeVore, Richard A. Eiferman, Edwin U. Keates